Deziglipel (INN; developmental code name MKP10241) is a GPR119 agonist with antihyperglycemic actions which is under development for the treatment of obesity and type 2 diabetes.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.